<p>The indicated MCC and melanoma cell lines were incubated with LY-294002 at three different concentrations. After the indicated time period the cells were subjected to the MTS assay in triplicates. The reduction in extinction relative to the DMSO (solvent of LY-294002) controls is depicted. The graphs represent mean values (± standard deviation) of at least three independent experiments.</p
<p>LOVO (KRAS<sup>G13D</sup>), HCT116 (KRAS<sup>G13D</sup>/PIK3CA<sup>H1047R</sup>), WIDR (BRAF<sup>...
<p>(<b>A</b>) PI3K inhibitor LY294002 (LY) decreases doxorubicin efflux in cell lines 10B and A549. ...
<p>C6 glioma cells were treated with PI3K inhibitor LY294002 (LY, 20 µmol/L), or/and tamoxifen (TAM,...
<p><b>A.</b> (Left) Western blot analysis of phospho Akt (S473) and phospho pS6 signals in C6 T-ALL ...
<p>A panel of NB cell lines (A) and MB cell lines (B) were incubated with increasing concentrations ...
<p>When MK-2206 was combined with the mTOR inhibitor rapamycin, synergistic cytotoxicity was observe...
<p><b>A)</b> ECAR (mpH/min) of MKL-1, MKL-2 and WaGa lines (minutes). Cells were treated with oligom...
<p>(A-C) Cells were treated with indicated concentrations of PIK-90, BKM-120 or INK128 for 1 hour an...
<p>Luminex profiling of MMPs, cytokines, chemokines and growth factors demonstrates that Mtb infecti...
<p>The cells were transfected with miR-223 inhibitor or its control and were sensitized with anti-DN...
<p>DMSO or compound was added to K562 cells at a final concentration of 1% or 10 μM, respectively, a...
<p>The viability curves of B cells and PBMCs after four days of incubation with different concentrat...
<p><b>A.</b> Resistance to PI3Ki is correlated to increased pERK. Western blots of proteins isolated...
<p>Confluent IEC18 cell monolayers were pretreated for 30 minutes with the specific inhibitor of PI3...
<p>(A) Cell spreading assay of MDCK+CADM1-GFP cells incubated on IgG or CADM1-EC-Fc in the presence ...
<p>LOVO (KRAS<sup>G13D</sup>), HCT116 (KRAS<sup>G13D</sup>/PIK3CA<sup>H1047R</sup>), WIDR (BRAF<sup>...
<p>(<b>A</b>) PI3K inhibitor LY294002 (LY) decreases doxorubicin efflux in cell lines 10B and A549. ...
<p>C6 glioma cells were treated with PI3K inhibitor LY294002 (LY, 20 µmol/L), or/and tamoxifen (TAM,...
<p><b>A.</b> (Left) Western blot analysis of phospho Akt (S473) and phospho pS6 signals in C6 T-ALL ...
<p>A panel of NB cell lines (A) and MB cell lines (B) were incubated with increasing concentrations ...
<p>When MK-2206 was combined with the mTOR inhibitor rapamycin, synergistic cytotoxicity was observe...
<p><b>A)</b> ECAR (mpH/min) of MKL-1, MKL-2 and WaGa lines (minutes). Cells were treated with oligom...
<p>(A-C) Cells were treated with indicated concentrations of PIK-90, BKM-120 or INK128 for 1 hour an...
<p>Luminex profiling of MMPs, cytokines, chemokines and growth factors demonstrates that Mtb infecti...
<p>The cells were transfected with miR-223 inhibitor or its control and were sensitized with anti-DN...
<p>DMSO or compound was added to K562 cells at a final concentration of 1% or 10 μM, respectively, a...
<p>The viability curves of B cells and PBMCs after four days of incubation with different concentrat...
<p><b>A.</b> Resistance to PI3Ki is correlated to increased pERK. Western blots of proteins isolated...
<p>Confluent IEC18 cell monolayers were pretreated for 30 minutes with the specific inhibitor of PI3...
<p>(A) Cell spreading assay of MDCK+CADM1-GFP cells incubated on IgG or CADM1-EC-Fc in the presence ...
<p>LOVO (KRAS<sup>G13D</sup>), HCT116 (KRAS<sup>G13D</sup>/PIK3CA<sup>H1047R</sup>), WIDR (BRAF<sup>...
<p>(<b>A</b>) PI3K inhibitor LY294002 (LY) decreases doxorubicin efflux in cell lines 10B and A549. ...
<p>C6 glioma cells were treated with PI3K inhibitor LY294002 (LY, 20 µmol/L), or/and tamoxifen (TAM,...